NCT06952855

Brief Summary

This observational study is a prospective, multi-institutional non intervention study to examine the prescription patterns, corresponding treatment effects and safety in routine clinical practice for patients prescribed for the treatment of gastroesophageal reflux disease.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
5,536

participants targeted

Target at P75+ for all trials

Timeline
Completed

Started Nov 2024

Shorter than P25 for all trials

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

November 1, 2024

Completed
4 months until next milestone

First Submitted

Initial submission to the registry

March 11, 2025

Completed
1 month until next milestone

Primary Completion

Last participant's last visit for primary outcome

April 23, 2025

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

April 23, 2025

Completed
8 days until next milestone

First Posted

Study publicly available on registry

May 1, 2025

Completed
Last Updated

May 13, 2025

Status Verified

May 1, 2025

Enrollment Period

6 months

First QC Date

March 11, 2025

Last Update Submit

May 11, 2025

Conditions

Erosive Reflux DiseaseHeartburnAcid Regurgitation

Keywords

GERDERD

Outcome Measures

Primary Outcomes (1)

  • Change in GERD (heartburn, acid regurgitation) score in RDQ

    Scale(none / 1day / 2day/ 3-4 day / 5-6 day/ every day)

    4 weeks

Study Arms (1)

1 cohort

No interventions

Eligibility Criteria

Age19 Years+
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)
Sampling MethodNon-Probability Sample
Study Population

GERD patients

You may qualify if:

  • An adult over 19 years of age
  • A person who voluntarily provides written informed consent

You may not qualify if:

  • A pregnant woman or a nursing woman
  • A person who is deemed unsuitable for the subject of the study

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Goodbreath Medical Center

Seoul, Gyeonggi-do, 15865, South Korea

Location

MeSH Terms

Conditions

HeartburnGastroesophageal Reflux

Condition Hierarchy (Ancestors)

Signs and Symptoms, DigestiveSigns and SymptomsPathological Conditions, Signs and SymptomsEsophageal Motility DisordersDeglutition DisordersEsophageal DiseasesGastrointestinal DiseasesDigestive System Diseases

Study Design

Study Type
observational
Observational Model
OTHER
Time Perspective
PROSPECTIVE
Sponsor Type
INDUSTRY
Responsible Party
SPONSOR

Study Record Dates

First Submitted

March 11, 2025

First Posted

May 1, 2025

Study Start

November 1, 2024

Primary Completion

April 23, 2025

Study Completion

April 23, 2025

Last Updated

May 13, 2025

Record last verified: 2025-05

Locations

KR(1)